Suppr超能文献

牛眼组织中的一氧化氮合酶活性。

Nitric oxide synthase activity in tissues of the bovine eye.

作者信息

Geyer O, Podos S M, Mittag T

机构信息

Department of Ophthalmology, Tel-Aviv Sourasky Medical Center, Israel.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1997 Dec;235(12):786-93. doi: 10.1007/BF02332864.

Abstract

BACKGROUND

Nitric oxide synthase (NOS) is present in many ocular tissues where it may have different physiological functions. This warrants a thorough characterization of NOS activity in the eye.

METHODS

NOS distribution and its biochemical properties were determined in the retina, choroid, ciliary processes (CP), and trabecular meshwork (TM).

RESULTS

Retinal NOS required NADPH (diphenylene-iodonium, a flavoprotein inhibitor, which inhibited enzyme activity with an IC50 of 0.36 microM, FAD (40 microM), FMN (40 microM), and BH4 (4 microM) as cofactors for optimal activity. Ocular NOS appeared to be regulated by free divalent cations, since its activity was inhibited by EDTA (slopes > 3.0 and IC50 values of 12.8, 19.7, and 53 microM, respectively). Ocular NOS required calmodulin, since NOS activity was inhibited by trifluoperazine (calmodulin inhibitor, IC50 = 41 microM). NOS activity is widely distributed in the eye, (choroid > retina > CP > TM) and is mainly cytosolic (70-95%). L-Arginine analogs inhibited NOS in the retina, choroid, and TM. In all three tissues, NG-methyl-L-arginine displayed the highest affinity for inhibition (IC50 = 0.2-0.7 microM) followed by canavanine (IC50 = 13-33 microM), while aminoguanidine only weakly inhibited NOS (IC50 = 93-179 microM).

CONCLUSION

In all tissues, the order of potency of inhibition points to the presence of constitutive rather than inducible NOS. Moreover, it is possible that TM contains more than a single form of NOS.

摘要

背景

一氧化氮合酶(NOS)存在于许多眼组织中,在这些组织中它可能具有不同的生理功能。这就需要对眼中NOS的活性进行全面表征。

方法

测定视网膜、脉络膜、睫状体突(CP)和小梁网(TM)中NOS的分布及其生化特性。

结果

视网膜NOS需要NADPH(二苯碘鎓,一种黄素蛋白抑制剂,以0.36微摩尔的IC50抑制酶活性)、FAD(40微摩尔)、FMN(40微摩尔)和BH4(4微摩尔)作为辅因子以实现最佳活性。眼NOS似乎受游离二价阳离子调节,因为其活性被EDTA抑制(斜率>3.0,IC50值分别为12.8、19.7和53微摩尔)。眼NOS需要钙调蛋白,因为NOS活性被三氟拉嗪(钙调蛋白抑制剂,IC50 = 41微摩尔)抑制。NOS活性在眼中广泛分布(脉络膜>视网膜>CP>TM),且主要存在于胞质溶胶中(70 - 95%)。L - 精氨酸类似物抑制视网膜、脉络膜和TM中的NOS。在所有这三种组织中,NG - 甲基 - L - 精氨酸对抑制表现出最高亲和力(IC50 = 0.2 - 0.7微摩尔),其次是刀豆氨酸(IC50 = 13 - 33微摩尔),而氨基胍仅对NOS有微弱抑制作用(IC50 = 93 - 179微摩尔)。

结论

在所有组织中,抑制效力的顺序表明存在组成型而非诱导型NOS。此外,小梁网可能含有不止一种形式的NOS。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验